Pvg Asset Management Corp as of Sept. 30, 2022
Portfolio Holdings for Pvg Asset Management Corp
Pvg Asset Management Corp holds 37 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Direxion Daily S&P 500 Bear 1x Etf (SPDN) | 19.3 | $5.0M | 279k | 17.88 | |
| Ishares Etf 1-3 Yr Treasury Bond Etf (SHY) | 14.5 | $3.7M | 46k | 81.21 | |
| S&p 500 Indx Etf (IVV) | 12.8 | $3.3M | 9.2k | 358.67 | |
| Vanguard Index S&P 500 Etf (VOO) | 6.4 | $1.6M | 5.0k | 328.30 | |
| ProShares UltraShort S&P 500 Etf (SDS) | 5.9 | $1.5M | 28k | 54.57 | |
| Invesco QQQ TR ETF SERIES 1 Etf (QQQ) | 4.9 | $1.3M | 4.7k | 267.27 | |
| ProShares Short Russell 2000 Etf (RWM) | 4.7 | $1.2M | 46k | 26.36 | |
| Vanguard Russell 2000 ETF Etf (VTWO) | 4.5 | $1.2M | 18k | 66.63 | |
| ProShares Short S&P500 Etf (SH) | 3.4 | $876k | 51k | 17.28 | |
| SPDR Ser Tr S&P Oil & Gas ETF Etf (XOP) | 2.8 | $731k | 5.9k | 124.72 | |
| ProShares TR UltraShort QQQ Etf (QID) | 2.6 | $679k | 25k | 27.43 | |
| Checkpoint Therapeutics | 1.6 | $408k | 392k | 1.04 | |
| DV (DV) | 1.5 | $385k | 14k | 27.35 | |
| Baxter International (BAX) | 1.4 | $355k | 6.6k | 53.86 | |
| Blackstone Secd Lending (BXSL) | 1.3 | $346k | 15k | 22.74 | |
| Sarepta Therapeutics (SRPT) | 1.3 | $345k | 3.1k | 110.54 | |
| Fs Kkr Capital Corp (FSK) | 1.3 | $345k | 20k | 16.95 | |
| Alphabet Inc Class C cs (GOOG) | 1.2 | $320k | 3.3k | 96.15 | |
| 4068594 Enphase Energy (ENPH) | 1.2 | $318k | 1.1k | 277.47 | |
| Ishares Etf North American Tech-so Etf (IGV) | 1.0 | $267k | 1.1k | 250.13 | |
| Photronics (PLAB) | 0.9 | $229k | 16k | 14.62 | |
| Antero Midstream Corp antero midstream (AM) | 0.8 | $206k | 22k | 9.18 | |
| Generac Holdings (GNRC) | 0.8 | $205k | 1.2k | 178.14 | |
| Kinder Morgan (KMI) | 0.7 | $189k | 11k | 16.64 | |
| Bioxcel Therapeutics (BTAI) | 0.7 | $178k | 15k | 11.82 | |
| Ford Motor Company (F) | 0.6 | $160k | 14k | 11.20 | |
| Fortress Biotech | 0.3 | $82k | 96k | 0.86 | |
| PennantPark Investment (PNNT) | 0.2 | $64k | 12k | 5.46 | |
| Windtree Therapeutics | 0.2 | $56k | 187k | 0.30 | |
| Hepion Pharmaceuticals | 0.2 | $55k | 108k | 0.51 | |
| Biolinerx (BLRX) | 0.2 | $44k | 48k | 0.93 | |
| Qualis Innovations (QLIS) | 0.2 | $42k | 22k | 1.90 | |
| Viking Therapeutics (VKTX) | 0.2 | $40k | 15k | 2.72 | |
| Virios Therapeutics Ord (VIRI) | 0.1 | $31k | 81k | 0.38 | |
| Aileron Therapeutics | 0.1 | $24k | 118k | 0.21 | |
| Outlook Therapeutics | 0.1 | $20k | 17k | 1.22 | |
| Synlogic | 0.1 | $18k | 19k | 0.95 |
